马方综合征
Marfan syndrome
定义 英文原文(暂无中文)
Marfan syndrome is a systemic disease of connective tissue characterized by a variable combination of cardiovascular, musculo-skeletal, ophthalmic and pulmonary manifestations.
别名
MFS
基本事实
- 遗传方式
- 常染色体显性
- 发病年龄
- 各年龄段
- 患病率
- 1-5 / 10 000(Europe)
相关基因 1来自下位疾病
Orphanet 未在本条目上直接标注致病基因。下表由本组所属的下位疾病汇总而来,「来源条目」列给出基因实际标注在哪一个 ORPHA 条目上。
| 基因 | 名称 | 来源条目 |
|---|---|---|
| FBN1 | fibrillin 1 | ORPHA:284979 |
临床表型 68
极常见 99–80%10
- 主动脉瘤 HP:0004942
- 主动脉根部瘤 HP:0002616
- 细长指(趾) HP:0001166
- 慢性疲劳 HP:0012432
- 不成比例的高身材 HP:0001519
- 鸡胸 HP:0000768
- 扁平足 HP:0001763
- 修长的身材 HP:0001533
- 自发性气胸 HP:0002108
- 萎缩纹 HP:0001065
常见 79–30%24
- 颧骨形态异常 HP:0010668
- 主动脉夹层 HP:0002647
- 主动脉瓣反流 HP:0001659
- 关节痛/关节炎 HP:0005059
- 生主动脉动脉瘤 HP:0004970
- 牙列拥挤 HP:0000678
- 硬膜扩张 HP:0100775
- 晶状体异位 HP:0001083
- 腭高而窄 HP:0002705
- 眼球轴长度增加 HP:0007800
- 关节过度活动 HP:0001382
- 晶状体脱位 HP:0012019
- 晶状体半脱位 HP:0001132
- 二尖瓣反流 HP:0001653
- 二尖瓣脱垂 HP:0001634
- 近视 HP:0000545
- 脸狭窄 HP:0000275
- 漏斗胸 HP:0000767
- 髋臼内陷 HP:0003179
- 脊柱侧弯 HP:0002650
- 睡眠异常 HP:0002360
- 睡眠呼吸暂停 HP:0010535
- 三尖瓣脱垂 HP:0001704
- 视觉障碍 HP:0000505
偶见 29–5%34
- 左心室功能异常 HP:0005162
- 主动脉迂曲 HP:0006687
- 动脉夹层 HP:0005294
- 注意力缺陷多动障碍 HP:0007018
- 恶病质 HP:0004326
- 腭裂 HP:0000175
- 充血性心力衰竭 HP:0001635
- 腹部动脉扩张 HP:0002636
- 长头畸形 HP:0000268
- 下斜睑裂 HP:0000494
- 气肿 HP:0002097
- 扁平角膜 HP:0007720
- 青光眼 HP:0000501
- 咯血 HP:0002105
- 虹膜发育不全 HP:0007676
- 肌张力减退 HP:0001252
- 腹股沟疝 HP:0000023
- 失眠 HP:0100785
- 脊柱后凸畸形(驼背) HP:0002808
- 肘运动受限 HP:0002996
- 脑脊膜膨出 HP:0002435
- 小下颌 HP:0000347
- 二尖瓣钙化 HP:0004382
- 肌痛 HP:0003326
- 开牙合 HP:0010807
- 骨质减少 HP:0000938
- 骨质疏松 HP:0000939
- 肺动脉扩张 HP:0004927
- 骨密度降低 HP:0004349
- 视网膜脱离 HP:0000541
- 下颌后缩 HP:0000278
- 骨骼肌萎缩 HP:0003202
- 脊椎滑脱症 HP:0003302
- 室性心动过速 HP:0004756
近两年的全球研究 2,809L2
2024/10 起在 Europe PMC 检索所得,按发表时间倒序显示最近 20 篇。标题未译成中文——自动翻译需要接入 LLM 服务,尚未引入。
- 2026-10Allopurinol for Marfan Aortopathy: Pharmacogenomic Safety and Sex-Stratified Trial Design Warrant Consideration
- 2026-10Ventricular Arrhythmias in Marfan Syndrome: Prevalence and Clinical Correlates in a Multicenter Cohort
- 2026-10Selective Endovascular Aortic Repair in Connective Tissue Disease Patients Within a Multidisciplinary Program Achieves Comparable Outcomes in High-Risk Patients
- 2026-10Decision-Making in IVF: Restrictions on PGT-M Positive Embryo Transfers-A Qualitative Study
- 2026-09Molecular heterogeneity and diagnostic performance of phenotype-driven multigene panel testing in patients with marfanoid habitus
- 2026-09开放获取SCTS Annual Meeting 2025: Abstracts
- 2026-09Accuracy of intraocular lens power calculation in pediatric aphakia with the Artisan iris-claw lens
- 2026-09开放获取Health-related quality of life, psychological well-being and physical activity in patients with mild-to-moderate ascending aortic dilation - a cross-sectional case-control study
- 2026-09综述开放获取Standardizing the Yamane flanged intrascleral haptic fixation: A framework for efficacy, complication mitigation, and reproducible training
- 2026-09综述病例报告开放获取Tangier Disease
- 2026-09Exome-wide screening discovers novel pathogenic variants in Vietnamese primary congenital glaucoma patients
- 2026-09综述开放获取Congenital Chest Wall Deformities in Children: A Narrative Review
- 2026-09综述Introducing Allopurinol to the Medical Treatment of Marfan Syndrome: Advantages, Limitations, and Potential Extension to other Aortopathies
- 2026-09综述开放获取Smooth Muscle Cell Plasticity as a Central Determinant of Plaque Stability
- 2026-09Cautionary Data on Antihypertensives in Aortic Diseases
- 2026-09开放获取ADAR1 and ADAR2 Expression in the Thoracic Aortic Wall Correlates with Aneurysm Severity and Dissection Risk: Insights into A-to-I RNA Editing Dysregulation in Marfan Syndrome-Derived vSMCs
- 2026-09病例报告开放获取Light Adjustable Lens (LAL) using Yamane intrascleral flanged fixation for traumatic aphakia: A case report
- 2026-09TRPV4 is Associated with a Marfan Syndrome-Related Mechanosensitive Gene Program in Aortic Smooth Muscle Cells
- 2026-09综述FBN1-related connective tissue disorders: unraveling cardiovascular, skeletal, and ocular complications through TGF-β signaling dysregulation and genotypic correlations
- 2026-09开放获取Rare diseases in Brazil: a nationwide analysis of the diagnostic odyssey
境外已获批用于本病的药物 0L2
欧盟与美国均未检索到已获批用于本病的药物。
尚未获批的在研药物(3 项)
这些药已被欧盟或美国的监管机构认定为罕见病用药(英文 orphan drug designation,中文行业里通称「孤儿药资格」——「孤儿」说的是这类药市场太小、没有厂商愿意认领,不是在说病人)。但这只是一种监管身份:意味着监管机构给予研发上的激励,不代表这个药已被证明有效,也不代表将来一定能上市,绝大多数最终不会成药。列在这里是为了看清有哪些方向正在被尝试。
数据来自欧洲药品管理局(EMA)的药品与罕见病用药资格公开导出表,以及美国 FDA 的罕见病用药资格数据库(Orphan Drug Product Designation Database)。两边口径不同:欧盟一侧取的是当前状态仍为「已授权」的药品;美国一侧记录的是「曾获批准」这一事实,FDA 的公开表不追踪药物此后是否退市(例如 Relyvrio 于 2024 年撤市,表中仍记为已获批)。请以官方记录页为准。
在中国开展的临床试验 3L2
按病名在 ClinicalTrials.gov 检索、并校验研究中心含中国大陆而来。登记状态不等于现在真的能入组——务必按 NCT 号到原站核实,并与主治医生商量。
登记为可入组 1
- 招募中NCT07672210PregnAncy-Related Aortic DISsEction in China中国研究中心 4 个:Beijing、Guangzhou、Shanghai、Wuhan
其他状态的试验(2 项)
- 状态未知NCT05578469Surgical Treatment of Marfan Syndrome With Subluxation Lens中国研究中心 1 个:Hangzhou
- 已完成NCT07008274Laparoscopic Sleeve Gastrectomy-Induced Decline in Plasma Asprosin and Its Association With Metabolic Recovery中国研究中心 1 个:Yangzhou
中国境外的在招试验 19L2
这些试验在中国没有研究中心,通常无法直接报名——入组一般要求在当地居住并接受随访。列在这里是因为它另有用处:看清楚全世界正在试哪些药、做到了哪一期、由谁在做。把药名和 NCT 编号记下来去问主治医生,或据此进一步查该药是否已在境外获批、是否有拓展性用药(expanded access)通道。
CT.gov 报告命中 19 项,此处取回并展示最近的 15 项。
- 尚未开始招募NCT07793747Serum Asprosin, Metabolic Syndrome, and Cardiometabolic Risk in Rheumatoid Arthritis
- 尚未开始招募NCT07803198Asprosin in Behect Patients
- 尚未开始招募NCT07358533Metabolic Obesity in Normal Weight (MONW): Diagnostic Markers Stud波兰
- 尚未开始招募NCT07591844Effect of Periodontal Therapy on Asprosin in Stable Angina土耳其
- 尚未开始招募NCT07495267Nutritional Ketosis Marfan
- 尚未开始招募NCT07419386Clinical and Psychosocial Factors Associated With Physical Activity Level in Adults With Marfan Syndrome西班牙
- 尚未开始招募NCT07169669Multicentre Longitudinal Study of Bone Mineralisation Characteristics in Marfan Syndrome and Ehlers-Danlos Syndrome
- 招募中NCT06546137National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry巴西
- 尚未开始招募NCT06735313Changes in Salivary Asprosin, IL-39, IL-40 and IL-1β Levels in Diabetic Patients with Periodontitis土耳其
- 尚未开始招募NCT06592560Asprosin in Breast Cancer
- 招募中NCT06782230ScATtEred Rare Disease Biobanks: a Model of Sample/Data Collection With susTainablE and Shared Criteria意大利
- 招募中NCT06720883Robotically Assisted Surgery For Perihilar Cholangiocarcinoma: A Prospective Study意大利
- 招募中NCT05809323Marfan Syndrome Moderate Exercise Trial II美国
- 招募中NCT05838235Adapted Physical Activity Program (APA) for Effort Rehabilitation of Children and Teenagers With Marfan Syndrome法国
- 招募中NCT05702476Marfan Syndrome (MFS) and Facial Dysmorphism: Non-invasive 3D Assessment意大利
外部标识与链接
发现这一页有错误?告诉我 · 邮件主题会自动带上本页的 ORPHA 编号
本页数据来源
- 疾病定义、同义词、基因、表型、流行病学:Orphanet(CC BY 4.0)
- 中文病名:Orphanet 中文包,冻结于 2020-06-01
- 表型中文标签:HPO 简体中文翻译(CHPO 上游成果)